Next Issue
Volume 3, December
Previous Issue
Volume 3, June
 
 

Gastrointest. Disord., Volume 3, Issue 3 (September 2021) – 6 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
4 pages, 222 KiB  
Opinion
Crohn’s Disease: The infectious Disease Incorporated’s Perspective
by Gilles R.G. Monif
Gastrointest. Disord. 2021, 3(3), 138-141; https://doi.org/10.3390/gidisord3030015 - 25 Aug 2021
Cited by 1 | Viewed by 2769
Abstract
Infectious Diseases Incorporated (IDI) is an infectious disease think-tank, established in 1973. Crohn’s disease (CD) is a chronic, recurrent disease of the gastrointestinal tract that has reached epidemic proportions within industrialized nations. CD is said to be without cure. Since 2003, therapeutic interventions [...] Read more.
Infectious Diseases Incorporated (IDI) is an infectious disease think-tank, established in 1973. Crohn’s disease (CD) is a chronic, recurrent disease of the gastrointestinal tract that has reached epidemic proportions within industrialized nations. CD is said to be without cure. Since 2003, therapeutic interventions have focused on disruption of the pro-inflammatory Th1 response against an unknown antigen. In 2015, the Hruska Postulate was introduced and, in so doing, explained how, in the absence of acquired immunity, newborn infection by Mycobacterium avium subspecies paratuberculosis could cause fixation of the immune system’s Th1 response against the organism. The Hruska Postulate was utilized to answer all the documented epidemiological facts embedded in the natural history of Crohn’s disease and, in particular, why breastfeeding confers protection against the future development of Crohn’s disease. It is Infectious Diseases Incorporated’s (IDI) stated opinion that Crohn’s disease is both preventable and curable if treated appropriately in its early stages. Full article
(This article belongs to the Special Issue Crohn's Disease: Symptoms, Causes, Management and Treatment)
10 pages, 1040 KiB  
Case Report
Sustained Crohn’s Disease Remission with an Exclusive Elemental and Exclusion Diet: A Case Report
by Farhad Mehrtash
Gastrointest. Disord. 2021, 3(3), 129-137; https://doi.org/10.3390/gidisord3030014 - 12 Aug 2021
Cited by 2 | Viewed by 4336
Abstract
The incidence of inflammatory bowel diseases, such as Crohn’s disease (CD), is increasing worldwide. Despite several new therapeutics to treat CD, many patients fail to respond to their medications and inevitably face surgical resection. While genetics plays a role in CD, environmental factors [...] Read more.
The incidence of inflammatory bowel diseases, such as Crohn’s disease (CD), is increasing worldwide. Despite several new therapeutics to treat CD, many patients fail to respond to their medications and inevitably face surgical resection. While genetics plays a role in CD, environmental factors are potential triggers. Recent research from the past few years suggest that pro-inflammatory foods are associated with an increased risk of CD. Some studies have shown the benefit of including exclusion diets, such as the specific carbohydrate diet (SCD) and exclusive elemental diets, to induce CD remission, but published data is limited. This case study explores how an exclusive elemental and exclusion diet helped induce clinical and biochemical remission and radiologic healing in a young adult male who had failed to achieve remission using standard medical treatment. C-reactive protein (CRP), fecal calprotectin, and magnetic resonance enterography (MRE) served as objective markers of inflammation in this study. Full article
Show Figures

Figure 1

2 pages, 190 KiB  
Correction
Correction: Farrukh, A.; Mayberry, J. Apparent Disparities in Hospital Admission and Biologic Use in the Management of Inflammatory Bowel Disease between 2014–2018 in Some Black and Ethnic Minority (BEM) Populations in England. Gastrointest. Disord. 2020, 2, 144–151
by Affifa Farrukh and John Mayberry
Gastrointest. Disord. 2021, 3(3), 127-128; https://doi.org/10.3390/gidisord3030013 - 10 Aug 2021
Viewed by 2002
Abstract
The authors wish to make the following correction to this paper [...] Full article
14 pages, 615 KiB  
Review
Climate Change and Enteric Infections in the Canadian Arctic: Do We Know What’s on the Horizon?
by Emma Finlayson-Trick, Bronwyn Barker, Selina Manji, Sherilee L. Harper, Cedric P. Yansouni and David M. Goldfarb
Gastrointest. Disord. 2021, 3(3), 113-126; https://doi.org/10.3390/gidisord3030012 - 10 Aug 2021
Cited by 2 | Viewed by 4227
Abstract
The Canadian Arctic has a long history with diarrheal disease, including outbreaks of campylobacteriosis, giardiasis, and salmonellosis. Due to climate change, the Canadian Arctic is experiencing rapid environmental transformation, which not only threatens the livelihood of local Indigenous Peoples, but also supports the [...] Read more.
The Canadian Arctic has a long history with diarrheal disease, including outbreaks of campylobacteriosis, giardiasis, and salmonellosis. Due to climate change, the Canadian Arctic is experiencing rapid environmental transformation, which not only threatens the livelihood of local Indigenous Peoples, but also supports the spread, frequency, and intensity of enteric pathogen outbreaks. Advances in diagnostic testing and detection have brought to attention the current burden of disease due to Cryptosporidium, Campylobacter, and Helicobacter pylori. As climate change is known to influence pathogen transmission (e.g., food and water), Arctic communities need support in developing prevention and surveillance strategies that are culturally appropriate. This review aims to provide an overview of how climate change is currently and is expected to impact enteric pathogens in the Canadian Arctic. Full article
Show Figures

Figure 1

13 pages, 1283 KiB  
Article
Cardiomyocyte-Specific Circulating Cell-Free Methylated DNA in Esophageal Cancer Patients Treated with Chemoradiation
by Sarah Martinez Roth, Eveline E. Vietsch, Megan E. Barefoot, Marcel O. Schmidt, Matthew D. Park, Archana Ramesh, Michael R. Lindberg, Giuseppe Giaccone, Anna T. Riegel, Ana Barac, Keith Unger and Anton Wellstein
Gastrointest. Disord. 2021, 3(3), 100-112; https://doi.org/10.3390/gidisord3030011 - 30 Jul 2021
Cited by 1 | Viewed by 3055
Abstract
Thoracic high-dose radiation therapy (RT) for cancer has been associated with early and late cardiac toxicity. To assess altered rates of cardiomyocyte cell death due to RT we monitored changes in cardiomyocyte-specific, cell-free methylated DNA (cfDNA) shed into the circulation. Eleven patients with [...] Read more.
Thoracic high-dose radiation therapy (RT) for cancer has been associated with early and late cardiac toxicity. To assess altered rates of cardiomyocyte cell death due to RT we monitored changes in cardiomyocyte-specific, cell-free methylated DNA (cfDNA) shed into the circulation. Eleven patients with distal esophageal cancer treated with neoadjuvant chemoradiation to 50.4 Gy (RT) and concurrent carboplatin and paclitaxel were enrolled. Subjects underwent fasting blood draws prior to the initiation and after completion of RT as well as 4–6 months following RT. An island of six unmethylated CpGs in the FAM101A locus was used to identify cardiomyocyte-specific cfDNA in serum. After bisulfite treatment this specific cfDNA was quantified by amplicon sequencing at a depth of >35,000 reads/molecule. Cardiomyocyte-specific cfDNA was detectable before RT in the majority of patient samples and showed some distinct changes during the course of treatment and recovery. We propose that patient-specific cardiac damages in response to the treatment are indicated by these changes although co-morbidities may obscure treatment-specific events. Full article
Show Figures

Figure 1

4 pages, 210 KiB  
Editorial
Aspects of the Pathogenesis and Management of Inflammatory Bowel Diseases
by Andrew S. Day
Gastrointest. Disord. 2021, 3(3), 96-99; https://doi.org/10.3390/gidisord3030010 - 28 Jul 2021
Viewed by 2234
Abstract
Over the last two decades, inflammatory bowel disease (IBD) has been diagnosed more often in many countries around the world, including in parts of the world where IBD was previously uncommon [...] Full article
Previous Issue
Next Issue
Back to TopTop